Back

The effect of left bundle branch block on pharmacotherapy and changes of left ventricular ejection fraction after the rapid-up titration of guideline-directed medical therapy in heart failure

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: balancing titration and renal function Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pal Peter Schaffer

Gottsegen National Cardiovascular Center, Budapest (Hungary)

7 More presentations in this session

Presentation thumbnail
How do we treat patients with chronic kidney disease stages 4-5 and heart failure with reduced left ventricular ejection fraction? Impact on 1-year mortality and hospital admissions
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides
Presentation thumbnail
Association between up-titration of guideline-directed medical therapy and clinical outcomes in patients with chronic heart failure with reduced ejection fraction
Doctor Y. Agata (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Sector-level disparities in ESC-recommended GDMT implementation for patients with HFrEF: a real-world retrospective comparative study
Miss R. Niraula (Kobuleti, GE)
Abstract Slides
Presentation thumbnail
Beta-blocker dose titration, functional capacity, and all-cause mortality in patients with heart failure and reduced ejection fraction
Doctor K. Berge (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Sex-related differences in contemporary HFrEF management: insights from the Italian OpTIMa-HF Registry
Doctor F. Marzano (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart failure: balancing titration and renal function

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Left bundle branch block cardiomyopathy: an intriguing and defiant entity from diagnosis to treatment
22 May 2023
thumbnail
Congress Presentation
How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?
21 May 2023
thumbnail
Congress Presentation
The need and duration of BB therapy in post MI patients with preserved left ventricular ejection fraction: a meta-analysis
27 August 2021
thumbnail
Congress Presentation
The kinetic of left ventricle diastolic dysfunction during pharmacotherapy up-titration in patients with dilated cardiomyopathy.
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources